Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms.
- Authors
- Bloom, A Joseph; Baker, Timothy B; Chen, Li-Shiun; Breslau, Naomi; Hatsukami, Dorothy; Bierut, Laura J; Goate, Alison
- Year
- 2014
- Journal
- Human molecular genetics
- PMID
- 24045616
- DOI
- 10.1093/hmg/ddt432
- PMCID
- PMC3869360
Genome-wide significant associations with cigarettes per day (CPD) and risk for lung cancer and chronic obstructive pulmonary disease (COPD) were previously reported in a region of 19q13, including CYP2A6 (nicotine metabolism enzyme) and EGLN2 (hypoxia response). The associated single nucleotide polymorphisms (SNPs) were assumed to be proxies for functional variation in CYP2A6. Here, we demonstrate that when CYP2A6 and EGLN2 genotypes are analyzed together, the key EGLN2 variant, rs3733829, is not associated with nicotine metabolism independent of CYP2A6, but is nevertheless independently associated with CPD, and with breath carbon monoxide (CO), a phenotype associated with cigarette consumption and relevant to hypoxia. SNPs in EGLN2 are also associated with nicotine dependence and with smoking efficiency (CO/CPD). These results indicate a previously unappreciated novel mechanism behind genome-wide significant associations with cigarette consumption and disease risk unrelated to nicotine metabolism.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Debiased lasso after sample splitting for estimation and inference in high-dimensional generalized linear models. | Vazquez O et al. | — | 2025 | → |
| Biological and Genetic Mechanisms of COPD, Its Diagnosis, Treatment, and Relationship with Lung Cancer. | Czarnecka-Chrebelska KH et al. | — | 2023 | → |
| Investigation of the genetic effect of 56 tobacco-smoking susceptibility genes on DNA methylation and RNA expression in human brain. | Yang Z et al. | — | 2022 | → |
| Gene-based association analysis reveals involvement of LAMA5 and cell adhesion pathways in nicotine dependence in African- and European-American samples. | Fan R et al. | — | 2021 | → |
| Sex-specific nicotine sensitization and imprinting of self-administration in rats inform GWAS findings on human addiction phenotypes. | Kozlova A et al. | — | 2021 | → |
| SNPs within CHRNA5-A3-B4 and CYP2A6/B6, nicotine metabolite concentrations and nicotine dependence treatment success in smokers. | Hubacek JA et al. | — | 2021 | → |
| White Matter Integrity and Nicotine Dependence: Evaluating Vertical and Horizontal Pleiotropy. | Ye Z et al. | — | 2021 | → |
| Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci. | Erzurumluoglu AM et al. | — | 2020 | → |
| Translational Molecular Approaches in Substance Abuse Research. | Fulton SL et al. | — | 2020 | → |
| White matter integrity and nicotine dependence in smokers: evaluating vertical and horizontal pleiotropy | Ye Z et al. | — | 2020 | — |
| Strain-specific altered nicotine metabolism in 3,3'-diindolylmethane (DIM) exposed mice. | Bloom AJ et al. | — | 2019 | → |
| Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's disease. | Lang BM et al. | — | 2018 | → |
| Human Genetics of Addiction: New Insights and Future Directions. | Hancock DB et al. | — | 2018 | → |
| Preparing the Way: Exploiting Genomic Medicine to Stop Smoking. | Bierut LJ et al. | — | 2018 | → |
| The PHD1 oxygen sensor in health and disease. | Kennel KB et al. | — | 2018 | → |
| The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings. | Saccone NL et al. | — | 2018 | → |
| Use of polygenic risk scores of nicotine metabolism in predicting smoking behaviors. | Chen LS et al. | — | 2018 | → |
| Genomic mechanisms of transformation from chronic obstructive pulmonary disease to lung cancer. | Wang DC et al. | — | 2017 | → |
| Significant association of the CHRNB3-CHRNA6 gene cluster with nicotine dependence in the Chinese Han population. | Wen L et al. | — | 2017 | → |
| Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions. | Yang J et al. | — | 2016 | → |
| Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk. | Patel YM et al. | — | 2016 | → |
| A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism. | Loukola A et al. | — | 2015 | → |
| Association of chromosome 19 to lung cancer genotypes and phenotypes. | Wang X et al. | — | 2015 | → |
| EGLN2 and RNF150 genetic variants are associated with chronic obstructive pulmonary disease risk in the Chinese population. | Ding Y et al. | — | 2015 | → |
| Genetic control of gene expression at novel and established chronic obstructive pulmonary disease loci. | Castaldi PJ et al. | — | 2015 | → |
| Polygenic score × intervention moderation: an application of discrete-time survival analysis to modeling the timing of first tobacco use among urban youth. | Musci RJ et al. | — | 2015 | → |
| Genetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseases. | Ananthakrishnan AN et al. | — | 2014 | → |
| Genetics and smoking. | Loukola A et al. | — | 2014 | → |
| Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. | Cho MH et al. | — | 2014 | → |